90 related articles for article (PubMed ID: 11838370)
1. [p16INK4a exon 1 alpha knockout in mouse embryonic stem cells].
Gong ZM; Li J; Fu JL
Yi Chuan Xue Bao; 2002 Jan; 29(1):21-5. PubMed ID: 11838370
[TBL] [Abstract][Full Text] [Related]
2. [Conditional targeting of p16(INK4a)exon 1a in mouse embryonic stem cells].
Gong Z; Zheng J; Fu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):285-9. PubMed ID: 12170463
[TBL] [Abstract][Full Text] [Related]
3. [Study on a human tissue-type plasminogen activator mutant cDNA knocked-in the beta-casein gene site of murine ES cells].
Lin FY; Yang X; Deng JX; Chen HX; Huang PT
Yi Chuan Xue Bao; 2004 Jun; 31(6):558-64. PubMed ID: 15490872
[TBL] [Abstract][Full Text] [Related]
4. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
5. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
Sharpless NE; Bardeesy N; Lee KH; Carrasco D; Castrillon DH; Aguirre AJ; Wu EA; Horner JW; DePinho RA
Nature; 2001 Sep; 413(6851):86-91. PubMed ID: 11544531
[TBL] [Abstract][Full Text] [Related]
6. [Construction of gene targeting vector for duplicating p35Nck5a gene and its application in the gene targeting of ES cells].
Zhou CW; Fu JL; Xue H
Yi Chuan Xue Bao; 2000; 27(8):659-65. PubMed ID: 11055117
[TBL] [Abstract][Full Text] [Related]
7. Construction of engineered murine embryonic stem cells with conditional knockout of FGFR2 depending on Cre-loxP.
Jianmin W; Ruihua S; Lei C; Liangjun Y; Bo C; Jing S; Yuanbing G; Ling Z; Lin C
Biocell; 2006 Aug; 30(2):269-78. PubMed ID: 16972551
[TBL] [Abstract][Full Text] [Related]
8. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
9. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the INK4A/ARF locus in blood mononuclear cells.
Deligezer U; Erten N; Akisik EE; Dalay N
Ann Hematol; 2006 Feb; 85(2):102-7. PubMed ID: 16320052
[TBL] [Abstract][Full Text] [Related]
11. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
[TBL] [Abstract][Full Text] [Related]
12. Mouse embryonic stem cells efficiently lipofected with nuclear localization peptide result in a high yield of chimeric mice and retain germline transmission potency.
Ma H; Liu Q; Diamond SL; Pierce EA
Methods; 2004 Jun; 33(2):113-20. PubMed ID: 15121165
[TBL] [Abstract][Full Text] [Related]
13. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
15. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
[TBL] [Abstract][Full Text] [Related]
16. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors.
Akala OO; Park IK; Qian D; Pihalja M; Becker MW; Clarke MF
Nature; 2008 May; 453(7192):228-32. PubMed ID: 18418377
[TBL] [Abstract][Full Text] [Related]
17. [Vector construction for embryonic stem cell gene targeting of site specific point mutation mouse coagulation factor IX gene].
Li J; Dai X; Yang H; Fu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):356-9. PubMed ID: 10581342
[TBL] [Abstract][Full Text] [Related]
18. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
[TBL] [Abstract][Full Text] [Related]
19. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
20. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
